Deal involves a vaccine candidate called rVSV-EBOV that's under early development by BioProtection Systems.
Search Results - stltoday.com, St. Louis Post-Dispatch: Living
Mon, 11/24/2014 - 12:47pm
Deal involves a vaccine candidate called rVSV-EBOV that's under early development by BioProtection Systems.